Similarly, a recently approved antidiabetic agent of the same drug family, semaglutide, has been assessed in a double-blind phase 2 RCT in 320 patients with NASH without DM2, given subcutaneously once daily, at various doses, for 72 weeks (NCT02970942)
Li Y, Li L, Wadley R, Reddel SW, Qi JC, Archis C, et al
The MDL centers on allegations that drugs such as Ozempic, Wegovy, and related GLP-1 therapies can cause non-arteritic anterior ischemic optic neuropathy (NAION), a rare but serious condition that may result in abrupt and permanent vision impairment
1 Introduction Glucoraphanin (GRP) is a naturally occurring sulfur-containing compound mainly produced by cruciferous plants such as cauliflower, broccoli, radish, cabbage, arugula, kale, bok choy, Brussels sprouts, collards, and watercress
The synergy between the two receptor pathways is present even at low doses, which is an argument for tirzepatide-based microdosing over semaglutide-based microdosing from a metabolic standpoint
